{
    "SPADE_UN_19424": {
        "Sequence Information": {
            "Peptide Name": "AAG-WMR, AAG-W-Myxinidin [H3,6l;D4R;P11R]",
            "Sequence": "AAGWGLRRLLKYGKRS",
            "Sequence Length": 16,
            "Biological Activity": [
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Differential In Vitro and In Vivo Toxicities of Antimicrobial Peptide Prodrugs for Potential Use in Cystic Fibrosis.",
                    "Pubmed ID": "26902766",
                    "Reference": "Antimicrob Agents Chemother. 2016;60:2813-2821",
                    "Author": "Forde E, Schütte A, Reeves E, Greene CM, Humphreys H, Mall M, Fitzgerald-Hughes D, Devocelle M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26902766"
                }
            ],
            "Mass": 1832.16,
            "PI": 11.73,
            "Net Charge": 5,
            "Hydrophobicity": -0.66,
            "Frequent Amino Acids": "GLR",
            "Absent Amino Acids": "CDEFHIMNOPQTUV",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 5,
            "Polar Residues": 11,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_19424",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11861",
                    "Similarity": 1.0,
                    "Sequence": "EEEEAAAGWGLRRLLKYGKRS"
                },
                {
                    "SPADE_ID": "SPADE_UN_13063",
                    "Similarity": 1.0,
                    "Sequence": "GLDDLLKALLKAAGW"
                },
                {
                    "SPADE_ID": "SPADE_UN_13066",
                    "Similarity": 1.0,
                    "Sequence": "GLADAAKLLLKAAGW"
                }
            ],
            "Hemolytic Activity": "Cystic fibrosis bronchial epithelial cells CFBE41o-:IC50=>300 µM,Cystic fibrosis transformed epithelial cells CFTE29o-:IC50=>600 µM,Human neutrophils:IC50=>300 µM",
            "Target Organism": "Pseudomonas aeruginosa PAO1(MIC=32µg/ml),Pseudomonas aeruginosa BH01(MIC=8µg/ml),Pseudomonas aeruginosa BH02(MIC=16µg/ml),Pseudomonas aeruginosa BH03(MIC=32µg/ml),Pseudomonas aeruginosa BH04(MIC=16µg/ml)"
        }
    }
}